Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Cardiac Ablation Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Cardiac Ablation Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Cardiac Ablation Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Cardiac Ablation Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 11 Apr 2021
  • Report ID: HLT 00179
  • Pages:167
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

Global Cardiac Ablation Market is anticipated to rise at a value CAGR of 12.45% over 2019-2028. According to a study published by Insure Insights on the Global Cardiac Ablation Market. Cardiac ablation is a process that is used to scar small areas in the heart that causes heart rhythm problems. Thus can prevent the abnormal electrical signals or rhythms of the heart. Long, flexible tubes known as catheters are inserted through a vein or artery into the heart to transport energy in the form of heat or extreme cold to adjust the tissues in the heart that cause arrhythmia. The rise in the Healthcare expenditure is driving the market growth

Top Driver: The surge in Cardiovascular disorders around the globe.

The rise in the occurrence of Cardiovascular disorders around the globe, and the lifestyle habits like smoking, and consumption of alcohol are the primary factors driving the market growth. The surge in the elderly population and disorders like diabetes mellitus, mental stress has triggered the market revenue. Technological advancements, rise in the R&D investments, and favorable reimbursement scenario has significantly impacted the growth of the market.

RF ablators have made the highest segmental growth in the Global Cardiac Ablation Market

Based on the Product,  Radiofrequency (RF) ablators segment, have dominated the segmental growth due to the importance of radiofrequency (RF) ablators as it is widely used due to its high effectivity of as compared with other devices. RF ablators are considered as safe, reliable than others. These radiofrequency ablators offer an option of customization during the procedure; therefore, it is given more preference over others. Radiofrequency ablators are widely available and thus have boosted the overall, market

In terms of the Applications, Cardiac rhythm management segment has obtained the most remarkable growth owing to the rise in the incidences of people suffering from atrial fibrillation, and thus the need for efficient cardiac rhythm management has boosted the demand for cardiac ablation. In terms of the End User, Hospitals segment have obtained the most significant growth owing to the availability of better healthcare infrastructure and technologically advanced systems.

North America boosts the regional market due to the presence of key players   

North America has held the highest market growth owing to the presence of key players like Advanced Cardiac Therapeutics, Alcon Laboratories Inc., AngioDynamics, Inc., etc. The rise in R&D investments and favorable reimbursement have escalated the market revenue of the region.  Government initiatives for better patient’s care, technological advancements are further boosting the market growth. The rise in the geriatric population and lifestyle habits like consumption of alcohol and smoking have further contributed to the regional growth. The rise in medical tourism has significantly driven regional market growth

Product launches, Strategic Collaborations, Mergers, and Acquisition, are the major strategies of the competitors

The Players of the Global Cardiac Ablation Market is fragmented. Product launches, Collaborations, Mergers, and Acquisition, are strategies used by the competitors   The key competitors of the Global Cardiac Ablation Market are Boston Scientific Corporation, Advanced Cardiac Therapeutics, Alcon Laboratories Inc., AngioDynamics, Inc., AtriCure, Inc., Biosense Webster Inc., CONMED Corporation, Medtronic Plc, Olympus Corporation and St Jude Medical, Inc.

Medtronic Plc: Medtronic Plc, is one of the key competitors of the Global Cardiac Ablation Market; for instance, In June 2019, Medtronic Plc, had announced the acquisition of Epix Therapeutics, they are involved in the manufacturing of the Cardiac Ablation system. The deal was done for USD 316 million. The acquisition was made by Medtronic to strengthen its product portfolio with Cardiac Ablation systems.

Boston Scientific Corporation:  Boston Scientific Corporation is a popular competitor in the Global Cardiac Ablation Market. In August 2019, Boston Scientific Corporation had announced the acquisition of BTG; they are involved in the manufacturing of the minimally invasive device. The deal was done for USD 4.2 billion. The acquisition was made by Boston Scientific to strengthen its product portfolio in Patient care systems.

 Scope of the Report

By Product

  • Radiofrequency (RF) Ablators
  • Electrical Ablators
  • Others

By Application

  • Cardiac Rhythm Management
  • Open surgery
  • Others

By End User

  • Hospitals
  • Ambulatory surgical centers
  • Cardiac centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • LAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Cardiac Ablation Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Cardiac Ablation Market -Industry Snapshots

6.1             Overview

6.1.1          Global Cardiac Ablation Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Cardiac Ablation Market Analysis, by Product

7.1             Overview

7.2             Key Findings for Cardiac Ablation Market- By Product

7.2.1          Cardiac Ablation Market- Radiofrequency (RF) Ablators

7.2.2          Cardiac Ablation Market- Electrical Ablators

7.2.3          Cardiac Ablation Market- Others

Chapter 8           Global Cardiac Ablation Market Analysis, by Application

8.1             Overview

8.2             Key Findings for Cardiac Ablation Market- By Application

8.2.1          Cardiac Ablation Market- Cardiac Rhythm Management

8.2.2          Cardiac Ablation Market- Open surgery

8.2.3          Cardiac Ablation Market- Others

Chapter 9           Global Cardiac Ablation Market Analysis, by End User

9.1             Overview

9.2             Key Findings for Cardiac Ablation Market- By End User

9.2.1          Cardiac Ablation Market- Hospitals

9.2.2          Cardiac Ablation Market- Ambulatory surgical centers

9.2.3          Cardiac Ablation Market- Cardiac centers

Chapter 10       Cardiac Ablation Market Analysis by Region

10.1           Key Findings for Cardiac Ablation Market- By region

10.2           Overview

10.2.1       Global Cardiac Ablation Market Analysis, By Product, 2019 – 2028

10.2.2       Global Cardiac Ablation Market Analysis, By Application, 2019 – 2028

10.2.3       Global Cardiac Ablation Market Analysis, By End User, 2019 – 2028

10.3           Cardiac Ablation Market – North America

10.3.1       Overview

10.3.2       U.S.

10.3.3       Canada

10.3.4       Mexico

10.3.5       North America Market, By Product

10.3.6       North America Market, By Application

10.3.7       North America Market, By End User

10.4           Cardiac Ablation Market – Europe

10.4.1       Overview

10.4.2       Germany

10.4.3       United Kingdom

10.4.4       France

10.4.5       Italy

10.4.6       Rest Of Europe

10.4.7       Europe Market, By Product

10.4.8       Europe Market, By Application

10.4.9       Europe market by, End User

10.5           Cardiac Ablation Market – Asia Pacific

10.5.1       Overview

10.5.2       China

10.5.3       Japan

10.5.4       India

10.5.5       Rest of APAC

10.5.6       Asia Pacific Market, By Product

10.5.7       Asia Pacific Market, By Application

10.5.8       Asia Pacific Market, By End User

10.6           Cardiac Ablation Market – LAMEA

10.6.1       Overview

10.6.2       Middle East & Africa (MEA)

10.6.3       Latin America

10.6.4       Rest Of World

10.6.5       Latin America, Middle East and Africa Market, By Product

10.6.6       Latin America, Middle East and Africa Market, By Application

10.6.7       Latin America, Middle East and Africa Market, By End User

Chapter 11       Market Competition Analysis

11.1           Market Share/Positioning Analysis

11.1.1       Market Positioning of Key Vendors, 2019

11.1.2       Key Strategies Adopted by the Leading Players

11.1.3       Recent Developments

Chapter 12       Company Profiles- Snapshot

12.1           Boston Scientific Corporation

12.1.1       Business Fundamentals

12.1.2       Financial Snapshots

12.1.3       Product Portfolio

12.1.4       Recent Developments

12.2           Advanced Cardiac Therapeutics

12.3           Alcon Laboratories Inc.

12.4           AngioDynamics, Inc.

12.5           AtriCure, Inc

12.6           Biosense Webster Inc.

12.7           CONMED Corporation

12.8           Medtronic Plc

12.9           Olympus Corporation

12.10        St Jude Medical Inc.

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 13       Appendix

 

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report